| Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study M Roschewski, K Dunleavy, S Pittaluga, M Moorhead, F Pepin, K Kong, ... The Lancet Oncology 16 (5), 541-549, 2015 | 442 | 2015 |
| Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion X Sun, B Wu, HC Chiang, H Deng, X Zhang, W Xiong, J Liu, ... Nature 599 (7886), 673-678, 2021 | 167 | 2021 |
| Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry KA Oetjen, KE Lindblad, M Goswami, G Gui, PK Dagur, C Lai, LW Dillon, ... JCI insight 3 (23), 2018 | 155 | 2018 |
| Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: exploratory analyses of the phase III OAK study SM Gadgeel, RV Lukas, J Goldschmidt, P Conkling, K Park, D Cortinovis, ... Lung cancer 128, 105-112, 2019 | 152 | 2019 |
| Recent drug approvals for acute myeloid leukemia C Lai, K Doucette, K Norsworthy Journal of hematology & oncology 12 (1), 100, 2019 | 137 | 2019 |
| TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML J Vadakekolathu, C Lai, S Reeder, SE Church, T Hood, A Lourdusamy, ... Blood advances 4 (20), 5011-5024, 2020 | 108 | 2020 |
| Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia SL Saraf, X Zhang, T Kanias, JP Lash, RE Molokie, B Oza, C Lai, ... British journal of haematology 164 (5), 729-739, 2014 | 105 | 2014 |
| Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia ME Percival, C Lai, E Estey, CS Hourigan Blood reviews 31 (4), 185-192, 2017 | 102 | 2017 |
| Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia M Goswami, G Gui, LW Dillon, KE Lindblad, J Thompson, J Valdez, ... Journal for immunotherapy of cancer 10 (1), 2022 | 39 | 2022 |
| Recent advances in targeted therapies in acute myeloid leukemia RS Bhansali, KW Pratz, C Lai Journal of Hematology & Oncology 16 (1), 29, 2023 | 37 | 2023 |
| Technical advances in the measurement of residual disease in acute myeloid leukemia GW Roloff, C Lai, CS Hourigan, LW Dillon Journal of Clinical Medicine 6 (9), 87, 2017 | 37 | 2017 |
| Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia H Çelik, KE Lindblad, B Popescu, G Gui, M Goswami, J Valdez, ... Blood Advances 4 (2), 367-379, 2020 | 36 | 2020 |
| When the Minimal Becomes Measurable. CS Hourigan, M Goswami, M Battiwalla, AJ Barrett, S Sheela, JE Karp, ... Journal of clinical oncology: official journal of the American Society of …, 2016 | 31 | 2016 |
| Phase I study of dose-adjusted-Teddi-R with ibrutinib in untreated and relapsed/refractory primary CNS lymphoma K Dunleavy, CE Lai, M Roschewski, JN Brudno, B Widemann, S Pittaluga, ... Blood 126 (23), 472, 2015 | 31 | 2015 |
| Concurrent expression of MYC/BCL2 protein in newly diagnosed DLBCL is not associated with an inferior survival following EPOCH-R therapy K Dunleavy, S Pittaluga, M Shovlin, S Pack, SM Steinberg, CE Lai, ... Blood 122 (21), 3029, 2013 | 31 | 2013 |
| Safety and efficacy analyses of atezolizumab in advanced non-small cell lung cancer (NSCLC) patients with or without baseline brain metastases RV Lukas, M Gandhi, C O’hear, S Hu, C Lai, JD Patel Annals of Oncology 28, ii28, 2017 | 30 | 2017 |
| Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma K Dunleavy, S Pittaluga, M Shovlin, M Roschewski, C Lai, SM Steinberg, ... Haematologica 101 (1), e27, 2016 | 30 | 2016 |
| Personalized single-cell proteogenomics to distinguish acute myeloid leukemia from nonmalignant clonal hematopoiesis LW Dillon, J Ghannam, C Nosiri, G Gui, M Goswami, KR Calvo, ... Blood cancer discovery 2 (4), 319-325, 2021 | 28 | 2021 |
| Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia KE Lindblad, J Thompson, G Gui, J Valdez, T Worthy, H Tekleab, ... Blood 132 (Supplement 1), 1437-1437, 2018 | 27 | 2018 |
| Precision medicine for acute myeloid leukemia C Lai, JE Karp, CS Hourigan Expert review of hematology 9 (1), 1-3, 2016 | 27 | 2016 |
